Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Cerebrovascular Disorders

  Free Subscription

Articles published in Lancet

Retrieve available abstracts of 104 articles:
HTML format

Single Articles

    May 2021

  1. Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis.
    Lancet. 2021;397:1625-1636.
    PubMed     Abstract available

    April 2021
  2. DAWSON J, Liu CY, Francisco GE, Cramer SC, et al
    Vagus nerve stimulation paired with rehabilitation for upper limb motor function after ischaemic stroke (VNS-REHAB): a randomised, blinded, pivotal, device trial.
    Lancet. 2021;397:1545-1553.
    PubMed     Abstract available

  3. VAN DER MEIJ A, Wermer MJH
    Vagus nerve stimulation: a potential new treatment for ischaemic stroke.
    Lancet. 2021;397:1520-1521.

  4. GALLI M, Benenati S, Capodanno D, Franchi F, et al
    Guided versus standard antiplatelet therapy in patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis.
    Lancet. 2021;397:1470-1483.
    PubMed     Abstract available

  5. BAYAS A, Menacher M, Christ M, Behrens L, et al
    Bilateral superior ophthalmic vein thrombosis, ischaemic stroke, and immune thrombocytopenia after ChAdOx1 nCoV-19 vaccination.
    Lancet. 2021 Apr 14. pii: S0140-6736(21)00872.

    March 2021
  6. WAKSMAN R, Torguson R
    The vulnerable plaque detected: time to consider treatment.
    Lancet. 2021;397:943-945.

    February 2021
  7. BENJAMIN LA, Phiri T, Simister R, Solomon T, et al
    Recognising HIV infection in systems of care for stroke.
    Lancet. 2021;397:794.

  8. PANDIAN JD, Kalkonde Y, Sebastian IA, Bosch J, et al
    Recognising HIV infection in systems of care for stroke - Authors' reply.
    Lancet. 2021;397:794-795.

  9. LAMBRECHTS RA, Uyttenboogaart M, Drost G
    A vertebral artery halo sign indicates giant cell arteritis affecting the posterior circulation of the brain.
    Lancet. 2021;397:e6.

  10. LANGLEY RE, Gilbert DC, Duong T, Clarke NW, et al
    Transdermal oestradiol for androgen suppression in prostate cancer: long-term cardiovascular outcomes from the randomised Prostate Adenocarcinoma Transcutaneous Hormone (PATCH) trial programme.
    Lancet. 2021;397:581-591.
    PubMed     Abstract available

    January 2021
  11. POST R, Germans MR, Tjerkstra MA, Vergouwen MDI, et al
    Ultra-early tranexamic acid after subarachnoid haemorrhage (ULTRA): a randomised controlled trial.
    Lancet. 2021;397:112-118.
    PubMed     Abstract available

  12. GUILLAUME M, Lahary A, Zourdani L, Malandain E, et al
    A painless, sudden loss of vision in sickle cell anaemia: central retinal artery occlusion.
    Lancet. 2021;397:e1.

    December 2020
  13. SCOTT IU, Campochiaro PA, Newman NJ, Biousse V, et al
    Retinal vascular occlusions.
    Lancet. 2020;396:1927-1940.
    PubMed     Abstract available

    November 2020
  14. GENCER B, Marston NA, Im K, Cannon CP, et al
    Efficacy and safety of lowering LDL cholesterol in older patients: a systematic review and meta-analysis of randomised controlled trials.
    Lancet. 2020;396:1637-1643.
    PubMed     Abstract available

  15. THOMALLA G, Boutitie F, Ma H, Koga M, et al
    Intravenous alteplase for stroke with unknown time of onset guided by advanced imaging: systematic review and meta-analysis of individual patient data.
    Lancet. 2020 Nov 6. pii: S0140-6736(20)32163.
    PubMed     Abstract available

    October 2020
  16. BERNHARDT J, Urimubenshi G, Gandhi DBC, Eng JJ, et al
    Stroke rehabilitation in low-income and middle-income countries: a call to action.
    Lancet. 2020;396:1452-1462.
    PubMed     Abstract available

  17. PANDIAN JD, Kalkonde Y, Sebastian IA, Felix C, et al
    Stroke systems of care in low-income and middle-income countries: challenges and opportunities.
    Lancet. 2020;396:1443-1451.
    PubMed     Abstract available

  18. LANGHORNE P, Audebert HJ, Cadilhac DA, Kim J, et al
    Stroke systems of care in high-income countries: what is optimal?
    Lancet. 2020;396:1433-1442.
    PubMed     Abstract available

    September 2020

  19. NCD Countdown 2030: pathways to achieving Sustainable Development Goal target 3.4.
    Lancet. 2020;396:918-934.
    PubMed     Abstract available

  20. MAKKAR RR, Cheng W, Waksman R, Satler LF, et al
    Self-expanding intra-annular versus commercially available transcatheter heart valves in high and extreme risk patients with severe aortic stenosis (PORTICO IDE): a randomised, controlled, non-inferiority trial.
    Lancet. 2020;396:669-683.
    PubMed     Abstract available

    July 2020
  21. CAMPBELL BCV, Khatri P
    Lancet. 2020;396:129-142.
    PubMed     Abstract available

    June 2020

  22. Effects of a high-dose 24-h infusion of tranexamic acid on death and thromboembolic events in patients with acute gastrointestinal bleeding (HALT-IT): an international randomised, double-blind, placebo-controlled trial.
    Lancet. 2020;395:1927-1936.
    PubMed     Abstract available

  23. ABRAMSON J, Furberg C, Jewell N, Wright JM, et al
    Questioning statin therapy for older patients.
    Lancet. 2020;395:1831-1832.

    May 2020
  24. HOLMES JL, Brake S, Docherty M, Lilford R, et al
    Emergency ambulance services for heart attack and stroke during UK's COVID-19 lockdown.
    Lancet. 2020 May 14. pii: S0140-6736(20)31031.

  25. CHIARITO M, Sanz-Sanchez J, Cannata F, Cao D, et al
    Monotherapy with a P2Y12 inhibitor or aspirin for secondary prevention in patients with established atherosclerosis: a systematic review and meta-analysis.
    Lancet. 2020;395:1487-1495.
    PubMed     Abstract available

    April 2020
  26. GIMBEL M, Qaderdan K, Willemsen L, Hermanides R, et al
    Clopidogrel versus ticagrelor or prasugrel in patients aged 70 years or older with non-ST-elevation acute coronary syndrome (POPular AGE): the randomised, open-label, non-inferiority trial.
    Lancet. 2020;395:1374-1381.
    PubMed     Abstract available

    February 2020
  27. SEN A, Jette N, Husain M, Sander JW, et al
    Epilepsy in older people.
    Lancet. 2020;395:735-748.
    PubMed     Abstract available

  28. HILL MD, Goyal M, Menon BK, Nogueira RG, et al
    Efficacy and safety of nerinetide for the treatment of acute ischaemic stroke (ESCAPE-NA1): a multicentre, double-blind, randomised controlled trial.
    Lancet. 2020 Feb 20. pii: S0140-6736(20)30258.
    PubMed     Abstract available

    Nerinetide before reperfusion in acute ischaemic stroke: deja vu or new insights?
    Lancet. 2020 Feb 20. pii: S0140-6736(20)30316.

  30. LIU L, Yin M, Liu S, Hu M, et al
    Facial filler causes stroke after development of cerebral fat embolism.
    Lancet. 2020;395:449.

  31. NEGRINI S, Arienti C, Kiekens C
    Usual care: the big but unmanaged problem of rehabilitation evidence.
    Lancet. 2020;395:337.

    January 2020
  32. KELLNER CP, Song R, Troiani ZS, Ascanio LC, et al
    Minimally invasive endoscopic evacuation of intracerebral haemorrhage: reaching the goal.
    Lancet. 2020;395:e5.

    December 2019
  33. HOLM NR, Makikallio T, Lindsay MM, Spence MS, et al
    Percutaneous coronary angioplasty versus coronary artery bypass grafting in the treatment of unprotected left main stenosis: updated 5-year outcomes from the randomised, non-inferiority NOBLE trial.
    Lancet. 2019 Dec 23. pii: S0140-6736(19)32972.
    PubMed     Abstract available

    November 2019
    Stroke: the doctor as patient.
    Lancet. 2019;394:1984-1985.

  35. Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury (CRASH-3): a randomised, placebo-controlled trial.
    Lancet. 2019;394:1713-1723.
    PubMed     Abstract available

    October 2019
    Don't be the one: individual responsibility in stroke prevention.
    Lancet. 2019;394:1482.

  37. SUCHARD MA, Schuemie MJ, Krumholz HM, You SC, et al
    Comprehensive comparative effectiveness and safety of first-line antihypertensive drug classes: a systematic, multinational, large-scale analysis.
    Lancet. 2019 Oct 24. pii: S0140-6736(19)32317.
    PubMed     Abstract available

    Preventing unnecessary disability after stroke in Scotland.
    Lancet. 2019;394:1225-1226.

    September 2019
  39. ZHOU M, Wang H, Zeng X, Yin P, et al
    Mortality, morbidity, and risk factors in China and its provinces, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
    Lancet. 2019;394:1145-1158.
    PubMed     Abstract available

  40. VRANCKX P, Valgimigli M, Eckardt L, Tijssen J, et al
    Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation (ENTRUST-AF PCI): a randomised, open-label, phase 3b trial.
    Lancet. 2019 Sep 2. pii: S0140-6736(19)31872.
    PubMed     Abstract available

    August 2019
  41. BHATT DL, Steg PG, Mehta SR, Leiter LA, et al
    Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial.
    Lancet. 2019 Aug 30. pii: S0140-6736(19)31887.
    PubMed     Abstract available

  42. HANLEY DF, Ziai WC, Zuccarello M, Awad IA, et al
    Surgery for intracerebral haemorrhage - Authors' reply.
    Lancet. 2019;394:e22-e23.

  43. KOLIAS AG, Marcus HJ, Broekman ML, Hutchinson PJ, et al
    Surgery for intracerebral haemorrhage.
    Lancet. 2019;394:e21.

  44. ENGRAND N, Mazighi M, Le Guerinel C, Dorison M, et al
    Surgery for intracerebral haemorrhage.
    Lancet. 2019;394:e20.

  45. ANDERSON CS, Bath PM
    Blood pressure reduction and intravenous thrombolysis - Authors' reply.
    Lancet. 2019;394:e25.

  46. KRUYT ND, Roos YB, Nederkoorn PJ
    Blood pressure reduction and intravenous thrombolysis.
    Lancet. 2019;394:e24.

  47. VLISIDES PE, Avidan MS, Mashour GA
    Uncovering covert stroke in surgical patients.
    Lancet. 2019 Aug 14. pii: S0140-6736(19)31770.

  48. Perioperative covert stroke in patients undergoing non-cardiac surgery (NeuroVISION): a prospective cohort study.
    Lancet. 2019 Aug 14. pii: S0140-6736(19)31795.
    PubMed     Abstract available

  49. OLIVIER-GOUGENHEIM L, Freychet C, Collardeau-Frachon S, Roure-Sobas C, et al
    A quest for Q fever.
    Lancet. 2019;394:419.

    July 2019
  50. SANDSET EC, Ford GA
    Sphenopalatine ganglion stimulation after stroke, promising but not yet ready for adoption.
    Lancet. 2019;394:189-190.

    June 2019
  51. GERSTEIN HC, Colhoun HM, Dagenais GR, Diaz R, et al
    Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial.
    Lancet. 2019 Jun 7. pii: S0140-6736(19)31149.
    PubMed     Abstract available

    May 2019
  52. BORNSTEIN NM, Saver JL, Diener HC, Gorelick PB, et al
    An injectable implant to stimulate the sphenopalatine ganglion for treatment of acute ischaemic stroke up to 24 h from onset (ImpACT-24B): an international, randomised, double-blind, sham-controlled, pivotal trial.
    Lancet. 2019 May 23. pii: S0140-6736(19)31192.
    PubMed     Abstract available

  53. ZIAI WC, Tsiskaridze A
    Restarting antiplatelet therapy after intracerebral haemorrhage.
    Lancet. 2019 May 21. pii: S0140-6736(19)31094.

  54. RODGERS H, Bosomworth H, Krebs HI, van Wijck F, et al
    Robot assisted training for the upper limb after stroke (RATULS): a multicentre randomised controlled trial.
    Lancet. 2019 May 21. pii: S0140-6736(19)31055.
    PubMed     Abstract available

  55. CAMPBELL BCV, Ma H, Ringleb PA, Parsons MW, et al
    Extending thrombolysis to 4.5-9 h and wake-up stroke using perfusion imaging: a systematic review and meta-analysis of individual patient data.
    Lancet. 2019 May 21. pii: S0140-6736(19)31053.
    PubMed     Abstract available

  56. Effects of antiplatelet therapy after stroke due to intracerebral haemorrhage (RESTART): a randomised, open-label trial.
    Lancet. 2019 May 21. pii: S0140-6736(19)30840.
    PubMed     Abstract available

  57. BERNHARDT J, Mehrholz J
    Robotic-assisted training after stroke: RATULS advances science.
    Lancet. 2019 May 21. pii: S0140-6736(19)31156.

  58. COUTTS SB, Menon BK
    Late thrombolysis for stroke works, but how do we do it?
    Lancet. 2019 May 21. pii: S0140-6736(19)31095.

    April 2019
  59. MCCALL B
    Alemtuzumab to be restricted pending review, says EMA.
    Lancet. 2019;393:1683.

  60. MILLWOOD IY, Walters RG, Mei XW, Guo Y, et al
    Conventional and genetic evidence on alcohol and vascular disease aetiology: a prospective study of 500 000 men and women in China.
    Lancet. 2019 Apr 4. pii: S0140-6736(18)31772.
    PubMed     Abstract available

    March 2019
  61. MENON BK, Goyal M
    Thrombus aspiration or retrieval in acute ischaemic stroke.
    Lancet. 2019;393:962-963.

  62. TURK AS 3RD, Siddiqui A, Fifi JT, De Leacy RA, et al
    Aspiration thrombectomy versus stent retriever thrombectomy as first-line approach for large vessel occlusion (COMPASS): a multicentre, randomised, open label, blinded outcome, non-inferiority trial.
    Lancet. 2019;393:998-1008.
    PubMed     Abstract available

    February 2019
  63. SANDSET EC, Fischer U
    Blood pressure lowering in acute ischaemic stroke thrombolysis.
    Lancet. 2019 Feb 6. pii: S0140-6736(19)30196.

  64. HANLEY DF, Thompson RE, Rosenblum M, Yenokyan G, et al
    Efficacy and safety of minimally invasive surgery with thrombolysis in intracerebral haemorrhage evacuation (MISTIE III): a randomised, controlled, open-label, blinded endpoint phase 3 trial.
    Lancet. 2019 Feb 6. pii: S0140-6736(19)30195.
    PubMed     Abstract available

  65. SALMAN RA, Klijn CJM, Selim M
    Minimally invasive surgery plus alteplase for intracerebral haemorrhage.
    Lancet. 2019 Feb 6. pii: S0140-6736(19)30309.

  66. ANDERSON CS, Huang Y, Lindley RI, Chen X, et al
    Intensive blood pressure reduction with intravenous thrombolysis therapy for acute ischaemic stroke (ENCHANTED): an international, randomised, open-label, blinded-endpoint, phase 3 trial.
    Lancet. 2019 Feb 6. pii: S0140-6736(19)30038.
    PubMed     Abstract available

  67. JOHNSTON KC, Durkalski-Mauldin VL
    Considering prehospital stroke trials: did RIGHT-2 get it right?
    Lancet. 2019 Feb 5. pii: S0140-6736(19)30276.

  68. Prehospital transdermal glyceryl trinitrate in patients with ultra-acute presumed stroke (RIGHT-2): an ambulance-based, randomised, sham-controlled, blinded, phase 3 trial.
    Lancet. 2019 Feb 5. pii: S0140-6736(19)30194.
    PubMed     Abstract available

    January 2019
  69. POWER SP, O'Mahony D
    Diffuse large vessel giant cell arteritis found by (18)Fluorodeoxyglucose PET/CT imaging.
    Lancet. 2019;393:349.

    December 2018
    Fluoxetine and recovery after stroke.
    Lancet. 2018 Dec 4. pii: S0140-6736(18)32983.

  71. Effects of fluoxetine on functional outcomes after acute stroke (FOCUS): a pragmatic, double-blind, randomised, controlled trial.
    Lancet. 2018 Dec 4. pii: S0140-6736(18)32823.
    PubMed     Abstract available

    October 2018
  72. CHILAMKURTHY S, Ghosh R, Tanamala S, Biviji M, et al
    Deep learning algorithms for detection of critical findings in head CT scans: a retrospective study.
    Lancet. 2018 Oct 11. pii: S0140-6736(18)31645.
    PubMed     Abstract available

  73. PANDIAN JD, Gall SL, Kate MP, Silva GS, et al
    Prevention of stroke: a global perspective.
    Lancet. 2018;392:1269-1278.
    PubMed     Abstract available

  74. CORDONNIER C, Demchuk A, Ziai W, Anderson CS, et al
    Intracerebral haemorrhage: current approaches to acute management.
    Lancet. 2018;392:1257-1268.
    PubMed     Abstract available

  75. ZERNA C, Thomalla G, Campbell BCV, Rha JH, et al
    Current practice and future directions in the diagnosis and acute treatment of ischaemic stroke.
    Lancet. 2018;392:1247-1256.
    PubMed     Abstract available

    21st century management and prevention of stroke.
    Lancet. 2018;392:1167.

  77. HERNANDEZ AF, Green JB, Janmohamed S, D'Agostino RB Sr, et al
    Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial.
    Lancet. 2018 Oct 1. pii: S0140-6736(18)32261.
    PubMed     Abstract available

    September 2018
  78. BHATT DL
    Aspirin-still the GLOBAL LEADER in antiplatelet therapy.
    Lancet. 2018;392:896-897.

    August 2018
  79. VALGIMIGLI M, Frigoli E, Leonardi S, Vranckx P, et al
    Radial versus femoral access and bivalirudin versus unfractionated heparin in invasively managed patients with acute coronary syndrome (MATRIX): final 1-year results of a multicentre, randomised controlled trial.
    Lancet. 2018 Aug 24. pii: S0140-6736(18)31714.
    PubMed     Abstract available

  80. GAZIANO JM, Brotons C, Coppolecchia R, Cricelli C, et al
    Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial.
    Lancet. 2018 Aug 24. pii: S0140-6736(18)31924.
    PubMed     Abstract available

  81. ROTHWELL PM, Cook NR, Gaziano JM, Price JF, et al
    Effects of aspirin on risks of vascular events and cancer according to bodyweight and dose: analysis of individual patient data from randomised trials.
    Lancet. 2018;392:387-399.
    PubMed     Abstract available

    June 2018
  82. XIAO F, Tian X, Wang XF
    Antiphospholipid syndrome causing reversible internal carotid artery thrombosis.
    Lancet. 2018;391:2641.

  83. PATEL T, Tesfaldet B, Chowdhury I, Kettermann A, et al
    Endpoints in diabetes cardiovascular outcome trials.
    Lancet. 2018;391:2412.

  84. DEVEREAUX PJ, Duceppe E, Guyatt G, Tandon V, et al
    Dabigatran in patients with myocardial injury after non-cardiac surgery (MANAGE): an international, randomised, placebo-controlled trial.
    Lancet. 2018;391:2325-2334.
    PubMed     Abstract available

    May 2018
  85. LANGHORNE P, O'Donnell MJ, Chin SL, Zhang H, et al
    Practice patterns and outcomes after stroke across countries at different economic levels (INTERSTROKE): an international observational study.
    Lancet. 2018;391:2019-2027.
    PubMed     Abstract available

    Stroke units around the world: the success story continues.
    Lancet. 2018;391:1970-1971.

    Haemostatic treatment for intracerebral haemorrhage.
    Lancet. 2018 May 16. pii: S0140-6736(18)31040.

  88. SPRIGG N, Flaherty K, Appleton JP, Salman RA, et al
    Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage (TICH-2): an international randomised, placebo-controlled, phase 3 superiority trial.
    Lancet. 2018 May 15. pii: S0140-6736(18)31033.
    PubMed     Abstract available

    February 2018
  89. ABUKARESH A, Al-Abadlah R, Bottcher B, El-Essi K, et al
    Ischaemic stroke management at Al-Shifa Hospital in the Gaza Strip: a clinical audit.
    Lancet. 2018;391 Suppl 2:S7.
    PubMed     Abstract available

  90. ALKHATIB MN, Abd-Alghafoor T, Elmassry A, Albarqouni L, et al
    Management of acute ischaemic stroke at Nasser Hospital, Gaza Strip: a clinical audit.
    Lancet. 2018;391 Suppl 2:S28.
    PubMed     Abstract available

    Stroke-acting FAST at all ages.
    Lancet. 2018;391:514.

    January 2018
  92. ANAND SS, Bosch J, Eikelboom JW, Connolly SJ, et al
    Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial.
    Lancet. 2018;391:219-229.
    PubMed     Abstract available

    December 2017
    Learning from TARDIS: time for more focused trials in stroke prevention.
    Lancet. 2017 Dec 20. pii: S0140-6736(17)33309.

  94. BATH PM, Woodhouse LJ, Appleton JP, Beridze M, et al
    Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole versus clopidogrel alone or aspirin and dipyridamole in patients with acute cerebral ischaemia (TARDIS): a randomised, open-label, phase 3 superiority trial.
    Lancet. 2017 Dec 20. pii: S0140-6736(17)32849.
    PubMed     Abstract available

    November 2017
  95. CONNOLLY SJ, Eikelboom JW, Bosch J, Dagenais G, et al
    Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial.
    Lancet. 2017 Nov 10. pii: S0140-6736(17)32458.
    PubMed     Abstract available

    October 2017
  96. WOOD D, Eisele JL
    A global coalition for the fight against heart disease and stroke.
    Lancet. 2017 Oct 16. pii: S0140-6736(17)32676.

    August 2017
  97. VINEREANU D, Lopes RD, Bahit MC, Xavier D, et al
    A multifaceted intervention to improve treatment with oral anticoagulants in atrial fibrillation (IMPACT-AF): an international, cluster-randomised trial.
    Lancet. 2017 Aug 25. pii: S0140-6736(17)32165.
    PubMed     Abstract available

  98. SIBBING D, Aradi D, Jacobshagen C, Gross L, et al
    Guided de-escalation of antiplatelet treatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention (TROPICAL-ACS): a randomised, open-label, multicentre trial.
    Lancet. 2017 Aug 25. pii: S0140-6736(17)32155.
    PubMed     Abstract available

  99. JINATONGTHAI P, Kongwatcharapong J, Foo CY, Phrommintikul A, et al
    Comparative efficacy and safety of reperfusion therapy with fibrinolytic agents in patients with ST-segment elevation myocardial infarction: a systematic review and network meta-analysis.
    Lancet. 2017;390:747-759.
    PubMed     Abstract available

    July 2017
  100. WARE RE, de Montalembert M, Tshilolo L, Abboud MR, et al
    Sickle cell disease.
    Lancet. 2017;390:311-323.
    PubMed     Abstract available

  101. DESIMONE CV, Graff-Radford J, El-Harasis MA, Rabinstein AA, et al
    Cerebral amyloid angiopathy and implications for atrial fibrillation management.
    Lancet. 2017;390:9-11.

    May 2017
  102. RUTTY GN, Morgan B, Robinson C, Raj V, et al
    Diagnostic accuracy of post-mortem CT with targeted coronary angiography versus autopsy for coroner-requested post-mortem investigations: a prospective, masked, comparison study.
    Lancet. 2017 May 24. pii: S0140-6736(17)30333.
    PubMed     Abstract available

    April 2017
    The future of atrial fibrillation management: integrated care and stratified therapy.
    Lancet. 2017 Apr 28. pii: S0140-6736(17)31072.
    PubMed     Abstract available

    February 2017
  104. MACDONALD RL, Schweizer TA
    Spontaneous subarachnoid haemorrhage.
    Lancet. 2017;389:655-666.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Cerebrovascular Disorders is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.